TP53 and prostate cancer: The results of GSEA showed that the high-risk score was significantly enriched in pathways (i.e., prostatic cancer, non-small cell lung cancer, Wnt signal pathway, mTOR signal pathway, MAPK signal pathway, and the p53 signal pathway; Supplementary Figure 4G).